Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
IDR 412
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
PT Itama Ranoraya Tbk engages in the procurement of health goods in Indonesia. It offers non-electromedical sterile medical devices, in vitro diagnostic products, and other products. The company's products include ADS syringes, blood screening machines and reagents, apheresis machines, blood processing machines, rapid test products, vaccine refrigerators, masks, products for surgery in hospitals, ultrasound, and...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBITD.
Data is available to registered users only
Buy
Sell